Skip to main content
Loading

EVast Bio Inc.

February 26, 2024
Multiple Therapeutics
EVast Bio Inc.
EVast Bio is a US-based, clinical-stage biotech born as a result of ground-breaking work at C4C (https://c4c.cl). EVast Bio is devoted to exploring the vast potential of small Extracellular Vesicles (EVs) as nanotherapeutics and targeted delivery systems, enabling treatments that set new standards in medical innovation.
Testimonials

Conference Sponsors


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP